Weekly long-acting growth hormone versus daily growth hormone therapy on quality of life, efficacy, and safety in children with short stature: a systematic review and meta-analysis

Fan Liu, Linying Xiu, Wei Zhang, Chunhui Zang, Shuyu Wang

Open source

DOI
10.3389/fendo.2026.1907184
Published
2026-09-02
Container
Frontiers in Endocrinology
Publisher
Frontiers Media SA
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3389/fendo.2026.1907184,
  title = {Weekly long-acting growth hormone versus daily growth hormone therapy on quality of life, efficacy, and safety in children with short stature: a systematic review and meta-analysis},
  author = {Fan Liu and Linying Xiu and Wei Zhang and Chunhui Zang and Shuyu Wang},
  year = {2026},
  journal = {Frontiers in Endocrinology},
  doi = {10.3389/fendo.2026.1907184},
  url = {https://doi.org/10.3389/fendo.2026.1907184}
}

RIS

TY  - JOUR
TI  - Weekly long-acting growth hormone versus daily growth hormone therapy on quality of life, efficacy, and safety in children with short stature: a systematic review and meta-analysis
AU  - Fan Liu
AU  - Linying Xiu
AU  - Wei Zhang
AU  - Chunhui Zang
AU  - Shuyu Wang
PY  - 2026
JO  - Frontiers in Endocrinology
DO  - 10.3389/fendo.2026.1907184
UR  - https://doi.org/10.3389/fendo.2026.1907184
ER  - 

APA

Liu, F., Xiu, L., Zhang, W., Zang, C., & Wang, S. (2026). Weekly long-acting growth hormone versus daily growth hormone therapy on quality of life, efficacy, and safety in children with short stature: a systematic review and meta-analysis. Frontiers in Endocrinology. https://doi.org/10.3389/fendo.2026.1907184

Source records